 Clinical Trials as Topic
"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 8 | 9 | | 1997 | 2 | 9 | 11 | | 1998 | 0 | 8 | 8 | | 1999 | 0 | 9 | 9 | | 2000 | 0 | 9 | 9 | | 2001 | 1 | 17 | 18 | | 2002 | 3 | 22 | 25 | | 2003 | 2 | 19 | 21 | | 2004 | 2 | 22 | 24 | | 2005 | 5 | 28 | 33 | | 2006 | 6 | 18 | 24 | | 2007 | 7 | 23 | 30 | | 2008 | 8 | 20 | 28 | | 2009 | 12 | 23 | 35 | | 2010 | 7 | 27 | 34 | | 2011 | 10 | 28 | 38 | | 2012 | 12 | 23 | 35 | | 2013 | 10 | 19 | 29 | | 2014 | 6 | 24 | 30 | | 2015 | 7 | 29 | 36 | | 2016 | 8 | 29 | 37 | | 2017 | 14 | 28 | 42 | | 2018 | 16 | 21 | 37 | | 2019 | 9 | 36 | 45 | | 2020 | 12 | 33 | 45 | | 2021 | 13 | 17 | 30 | | 2022 | 3 | 23 | 26 | | 2023 | 0 | 9 | 9 | | 2024 | 11 | 22 | 33 | | 2025 | 15 | 18 | 33 | | 2026 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Montaser E, Williams C, Shah VN. Assessing Time Below Range as a Predictor of Severe Hypoglycemia: Insights From Six Clinical Trials. Diabetes Care. 2026 Mar 01; 49(3):483-489.
-
Dousa KM, Shin E, Kurz SG, Rubin EJ, Holland SM, Olivier KN, Daley CL, Kreiswirth BN, Pottinger PS, Bonomo RA. The Role of ß-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials. Clin Infect Dis. 2026 Feb 09; 82(1):e135-e145.
-
Morel A, Delacroix E, Rice JD, Austin S, Koeppe E, Hanson EN, Griggs JJ, Stoffel EM, Resnicow K. Quantifying the role of communication in recruitment status outcomes for a clinical trial on genetic testing uptake. Contemp Clin Trials. 2026 Feb; 161:108218.
-
Naik S, Aplenc R, Baumeister SHC, Becilli M, Bhagwat AS, Bonifant CL, Budde LE, Chien CD, Curran KJ, Daniyan AF, Dreyzin A, Gardner RA, Ghorashian S, Gottschalk S, Hill LC, Kohler ME, Lamble A, Locatelli F, Mamonkin M, Omer B, Park JH, Quintarelli C, Rambaldi B, Richards RM, Sallman DA, Sauer T, Shah NN, Subklewe M, Summers C, Tasian SK, Taylor N, Tettamanti S, Verneris MR, Velasquez MP, Gill SI. International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML. Blood Adv. 2025 Dec 09; 9(23):6047-6058.
-
Ata B, Montgomery RA, Ozyoruk YN, Parent B, Schold JD. A data-driven analysis of patient selection for xenotransplant human clinical trials. PLoS One. 2025; 20(12):e0335767.
-
Hirano I, Furuta GT, Falk GW, Ma C, Gonsalve N, Dellon ES. Review article: Seeing Is Believing-The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis. Aliment Pharmacol Ther. 2026 Feb; 63(3):341-351.
-
Montaser E, Abad SE, Shah VN. Changes in A1C Versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes. J Clin Endocrinol Metab. 2025 Nov 18; 110(12):e4182-e4187.
-
Schreiber AR, Verduzco-Aguirre HC, Giangiuli S, Aranda-Gutierrez A, Roy S, Soto-Perez-de-Celis E. A review of current and emerging therapies in breast cancer: implications for older adults. Expert Rev Clin Pharmacol. 2025 Oct; 18(10):1-16.
-
Kazerooni AF, Familiar AM, Aboian M, Brüningk SC, Vossough A, Linguraru MG, Huang RY, Hargrave D, Peet AC, Resnick AC, Storm PB, Mirsky D, Yeom KW, Weller M, Prados M, Chang SM, Mueller S, Villanueva-Meyer JE, Bakas S, Fangusaro J, Kann BH, Nabavizadeh A. Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation. Lancet Oncol. 2025 Nov; 26(11):e607-e618.
-
Baugh CM, Bolcic-Jankovic D, Fedyk M, Yarborough M, Hey SP, Hyun I, Kimmelman J, Campbell EG. Challenges of Conducting Risk-Benefit Analysis of Early Phase Clinical Trials: Results of a National Survey of IRB Chairs. Ethics Hum Res. 2025 Nov-Dec; 47(6):2-12.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|